NOT YET RECRUITING
NCT07416734
RCT of HeartBot in Women
The goal of this clinical trial is to find out whether an app-based program called HeartBot II, which uses an artificial intelligence (AI) chatbot, can help improve women's awareness and knowledge of heart attacks in women.
This is an online study with about 200 women taking part. Participants will be randomly assigned (by chance) to one of two groups: an intervention group or a wait-list control group.
Participants in the intervention group will begin using the HeartBot II program right away. Participants in the wait-list control group will wait 12 weeks before starting the HeartBot II program. The HeartBot II program includes four short modules. In each module, participants will interact with a chatbot and spend about 10 to 15 minutes completing the content.
Participants will be asked to complete an online screening and baseline survey at the start of the study, as well as two follow-up surveys at 12 weeks and 24 weeks.
Gender: FEMALE
Ages: 25 Years - Any
Participants Must be Women Aged 25 Years or Older
Participants Should Have no Self-reported History of Heart Disease or Stroke
Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease
+4